Skip to main content
Skip to section navigation
Skip to footer
News
Careers
Contact us
About Us
Overview
Management Team
Board of Directors
Our Values
Compliance and Transparency
Pipeline & Portfolio
Pipeline
Our Therapies
Science
Overview
Publications
Clinical Trials
Investors
Overview
News
Events & Presentations
Stock Info
Financials & Filings
Governance
IR Resources
Medical Information
Request medical information
US healthcare professionals
Grants and funding
News
Careers
Contact us
SEC Filings
Investors
Investors
Overview
News
Press Releases
Email Alerts
Events & Presentations
Events
Presentations
Stock Info
Quote and Chart
Historical Performance
Analyst Coverage
Financials & Filings
Financial Results
SEC Filings
Annual Reports
Email Alerts
Governance
Overview
Governance Documents
Management Team
Board of Directors
Board Committees
IR Resources
Investor FAQs
Email Alerts
Contacts
Filing Type:
View All
10-K
10-Q
144
20-F
3
4
424B4
424B5
424B7
6-K
6-K/A
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DRS
DRS/A
EFFECT
F-1
F-1/A
F-1MEF
F-3ASR
F-6
F-6/A
POSASR
PRE 14A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
Year:
View All
2025
2024
2023
2022
2021
2020
2016
Date
Form
Description
PDF
XBRL
Pages
01/15/21
F-1
Form F-1: Registration statement for securities of certain foreign private issuers
01/15/21 F-1 Documents
expand_more
EX-10.1
EX-10.2
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.13
EX-10.14
EX-10.15
EX-10.16
EX-10.17
EX-21.1
EX-23.1
EX-23.2
1074
12/30/20
SEC STAFF LETTER
Form SEC STAFF LETTER: SEC Staff Letter
1
12/22/20
DRS/A
Form DRS/A: Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
12/22/20 DRS/A Documents
expand_more
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-10.16
727
12/14/20
UPLOAD
Form UPLOAD: SEC-generated letter
12/14/20 UPLOAD Documents
expand_more
TEXT-EXTRACT
6
11/19/20
DRS/A
Form DRS/A: Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
308
11/17/20
DRS
Form DRS: Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
307
04/13/16
SC 13G
Form SC 13G: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
Page
18
Page
19
Page
20
Page
21
Select a page:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
email
Email Alerts
contact_page
Contacts
rss_feed
RSS News Feed
account_tree
Sitemap